Scrambled sgRNA CRISPR Lentivirus | Target Sequence GCACTCACATCGCTACATCA 貨號K019

| 代理廠牌: | ![]() |
| 原廠連結: | |
| 相關下載: |

Scrambled sgRNA CRISPR Lentivirus | 貨號K019
即用型Lentivirus提供力價107 IU/ml, 300ul
產品介紹: Abmgood提供一系列針對不同CRISPR目標序列, 設計sgRNA-CRISPR Lentivirus表現載體。超過90%的構建體將在20-90%的細胞中完全敲除。 大多數構建體> 50% transduced轉導和selected cells。 越來越多證據表明,sgRNA比shRNA和siRNA敲除機率高。購買sgRNA Vector, 如果設計用於Cas9核酸酶的sgRNA構建體沒有合理的敲除,將免費設計另一組3個構建體。需確保您盡可能地優化了您的實驗,包括(如適用)增加您的MOI(最多10次)和感染持續時間(最多72小時),並在進行clone screening克隆篩選。
於系統長非編碼RNAs (long non-coding RNAs): 該系統可以用於通過使用一對sgRNA敲除長的非編碼RNA或miRNA或任何短片段的DNA。 但是,效率將比敲除編碼蛋白質的基因低得多,約為1%。 因此,需要單細胞克隆。 可能設計3個靶向lncRNA開始和結束的sgRNA(3×2結構)。3×3的組合,用於敲除靶向的lncRNA,PCR篩選鑑定為最佳組合。可以在轉導2個最佳sgRNA後進行單細胞克隆。預計1-5%的克隆中,lncRNA將被完全敲除。
| Species | N/A |
| Vector | pLenti-U6-sgRNA-PGK-Neo |
| Target Sequence | GCACTCACATCGCTACATCA |
| Format | Virus |
| Appearance | Liquid |
| Storage | Lentiviruses are shipped with dry ice. For long term storage, it is recommended to store the viruses at -80°C in small aliquots to avoid repeated freeze-thaw cycles. |
| Shelf Life | 1 year (when at -80°C or below in a non-frost free freezer) |
| Shipping | Shipped with dry ice |
| Additional Materials | – CRISPR Genomic Cleavage Detection Kit (G932) |
| Quality Control | Restriction Enzyme Digest and Sequencing |
Jiang, G et al. “Isorhapontigenin (ISO) inhibits invasive bladder cancer (BC) formation in vivo and human BC invasion in vitro by targeting STAT1/FOXO1 Axis.” Cancer Prev Res. 9(7):567-580 (2016). DOI: 10.1158/1940-6207.CAPR-15-0338.
Sun, J et al. “Protein Phosphatase, Mg2+/Mn2+-dependent 1A controls the innate antiviral and antibacterial response of macrophages during HIV-1 and Mycobacterium tuberculosis infection.” Oncotarget 7 (13):15394-409 (2016). DOI: 10.18632/oncotarget.8190. PubMed: 27004401. Application: CRISPR KO.
Kang, YJ et al. “Regulation of NKT cell-mediated immune responses to tumours and liver inflammation by mitochondrial PGAM5-Drp1 signalling.” Nat. Commun. 6:8371 (2015). DOI: 10.1038/ncomms9371.
Okugawa, Y et al. “Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer.” Gut : (2015). DOI: 10.1136/gutjnl-2015-309359. PubMed: 26475630.
